Green Shoots for Dealmaking

Authored by Jacob Ambrose Willson, Senior Editor, Criticaleye

There’s no denying that the macroeconomic environment has posed a significant challenge to businesses looking to execute growth via dealmaking. However, there have been some positive signs of late, according to participants during Criticaleye’s recent Growth Company Forum. Senior Editor Jacob Ambrose Willson summarises their thoughts below.


Featuring commentary from:

Stuart Andrews, co-CEO, Zeus Capital
Grant Humphrey, Partner, Strategy and Transactions, EY
James Wilson, Corporate Partner, DWF
Matthew Blagg, CEO, Criticaleye 
Tracey Groves, Head of ESG & Sustainability Advisory Practice, Partner, DWF
 

Share this with your Community


Contributors
Grant Humphrey
Partner, Strategy and Transactions
EY, More London Place
James Wilson
Partner, London
DWF Group
Matthew Blagg
CEO
Criticaleye
Stuart Andrews
Former Co-CEO
Zeus Capital
Tracey Groves
Head of ESG & Sustainability Advisory Practice, Partner
DWF Group


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Powering Up for the Public Markets

Thomas Ryder, founder and CEO of international sports brand Applied Nutrition, recounts the remarkable journey the business has been on since 2014 – from humble beginnings to an IPO on the London Stock Exchange an...


Inspiring Leaders Podcast: Navigating Capital Markets with Confidence

Dave Wilson, Chair of LBG Media (LADbible) and Knights plc, joins Criticaleye’s Senior Editor Jacob Ambrose Willson to explore how Boards and executive teams can successfully navigate today’s capital mark...


Click here to download this insight

Driving Growth and Value as CFO

Ithaca Energy has developed into a major player in the North Sea oil industry during Iain Lewis’ three years as CFO. In this interview with Criticaleye, he discusses the company’s IPO in 2022, its M&A st...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 72




GlaxoSmithKline plc LACE Partners Hitachi Solutions London Stock Exchange Group Drax Group plc NATS Worldpay Legal & General AlixPartners Aldermore Group NatWest Group Canaccord Genuity Group Inc British Land Lightsource bp Rolls-Royce Mayborn Group E.ON UK